Katherine M Johnson, MD | |
119 Belmont St, Worcester, MA 01605-2903 | |
(508) 334-0550 | |
(508) 334-8412 |
Full Name | Katherine M Johnson |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 12 Years |
Location | 119 Belmont St, Worcester, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134481880 | NPI | - | NPPES |
110116654A | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 265750 (Massachusetts) | Secondary |
207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 265750 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Umass Memorial Medical Group Inc | 4284539891 | 1889 |
News Archive
Five scientists from the University of California, San Diego and its School of Medicine have been awarded almost $12 million in new grants from the California Institute for Regenerative Medicine (CIRM) to conduct stem cell-based research into regenerating spinal cord injuries, repairing gene mutations that cause amyotrophic lateral sclerosis and finding new drugs to treat heart failure and Alzheimer's disease.
Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterology, today announced record revenues of $74.9 million for the quarter ended June 30, 2010, an increase of 16% over revenues of $64.8 million for the quarter ended June 30, 2009. Revenues for the six-month period ended June 30, 2010 were a record $142.4 million, compared with $123.2 million for the corresponding period in 2009, a gain of 16%.
Dimension Data, the $6.7 billion global ICT solutions and services provider, today announced that it ranked 57th on the 2015 Healthcare Informatics (HCI) 100 list. This year's ranking marks the third year in row Dimension Data has been included on the list.
A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
Researchers from Lund University, together with the Roche pharmaceutical company, have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer's disease.
› Verified 5 days ago
Entity Name | Umass Memorial Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
Five scientists from the University of California, San Diego and its School of Medicine have been awarded almost $12 million in new grants from the California Institute for Regenerative Medicine (CIRM) to conduct stem cell-based research into regenerating spinal cord injuries, repairing gene mutations that cause amyotrophic lateral sclerosis and finding new drugs to treat heart failure and Alzheimer's disease.
Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterology, today announced record revenues of $74.9 million for the quarter ended June 30, 2010, an increase of 16% over revenues of $64.8 million for the quarter ended June 30, 2009. Revenues for the six-month period ended June 30, 2010 were a record $142.4 million, compared with $123.2 million for the corresponding period in 2009, a gain of 16%.
Dimension Data, the $6.7 billion global ICT solutions and services provider, today announced that it ranked 57th on the 2015 Healthcare Informatics (HCI) 100 list. This year's ranking marks the third year in row Dimension Data has been included on the list.
A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
Researchers from Lund University, together with the Roche pharmaceutical company, have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer's disease.
› Verified 5 days ago
Entity Name | Reliant Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720017528 PECOS PAC ID: 5597755322 Enrollment ID: O20040708000650 |
News Archive
Five scientists from the University of California, San Diego and its School of Medicine have been awarded almost $12 million in new grants from the California Institute for Regenerative Medicine (CIRM) to conduct stem cell-based research into regenerating spinal cord injuries, repairing gene mutations that cause amyotrophic lateral sclerosis and finding new drugs to treat heart failure and Alzheimer's disease.
Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterology, today announced record revenues of $74.9 million for the quarter ended June 30, 2010, an increase of 16% over revenues of $64.8 million for the quarter ended June 30, 2009. Revenues for the six-month period ended June 30, 2010 were a record $142.4 million, compared with $123.2 million for the corresponding period in 2009, a gain of 16%.
Dimension Data, the $6.7 billion global ICT solutions and services provider, today announced that it ranked 57th on the 2015 Healthcare Informatics (HCI) 100 list. This year's ranking marks the third year in row Dimension Data has been included on the list.
A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
Researchers from Lund University, together with the Roche pharmaceutical company, have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer's disease.
› Verified 5 days ago
Entity Name | Beth Israel Deaconess Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548202641 PECOS PAC ID: 8123936119 Enrollment ID: O20041001000827 |
News Archive
Five scientists from the University of California, San Diego and its School of Medicine have been awarded almost $12 million in new grants from the California Institute for Regenerative Medicine (CIRM) to conduct stem cell-based research into regenerating spinal cord injuries, repairing gene mutations that cause amyotrophic lateral sclerosis and finding new drugs to treat heart failure and Alzheimer's disease.
Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterology, today announced record revenues of $74.9 million for the quarter ended June 30, 2010, an increase of 16% over revenues of $64.8 million for the quarter ended June 30, 2009. Revenues for the six-month period ended June 30, 2010 were a record $142.4 million, compared with $123.2 million for the corresponding period in 2009, a gain of 16%.
Dimension Data, the $6.7 billion global ICT solutions and services provider, today announced that it ranked 57th on the 2015 Healthcare Informatics (HCI) 100 list. This year's ranking marks the third year in row Dimension Data has been included on the list.
A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
Researchers from Lund University, together with the Roche pharmaceutical company, have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer's disease.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Katherine M Johnson, MD Po Box 415348, Boston, MA 02241-5348 Ph: (800) 225-8885 | Katherine M Johnson, MD 119 Belmont St, Worcester, MA 01605-2903 Ph: (508) 334-0550 |
News Archive
Five scientists from the University of California, San Diego and its School of Medicine have been awarded almost $12 million in new grants from the California Institute for Regenerative Medicine (CIRM) to conduct stem cell-based research into regenerating spinal cord injuries, repairing gene mutations that cause amyotrophic lateral sclerosis and finding new drugs to treat heart failure and Alzheimer's disease.
Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterology, today announced record revenues of $74.9 million for the quarter ended June 30, 2010, an increase of 16% over revenues of $64.8 million for the quarter ended June 30, 2009. Revenues for the six-month period ended June 30, 2010 were a record $142.4 million, compared with $123.2 million for the corresponding period in 2009, a gain of 16%.
Dimension Data, the $6.7 billion global ICT solutions and services provider, today announced that it ranked 57th on the 2015 Healthcare Informatics (HCI) 100 list. This year's ranking marks the third year in row Dimension Data has been included on the list.
A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
Researchers from Lund University, together with the Roche pharmaceutical company, have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer's disease.
› Verified 5 days ago
Benjamin D. Hamar, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-0550 Fax: 508-334-8412 | |
Tara J. Chute, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-1000 | |
Isabel Karlins Sausjord, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 119 Belmont St Apt 401, Worcester, MA 01605 Phone: 508-334-6388 | |
Leah Wilson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 328 Shrewsbury St, Ste 100, Worcester, MA 01604 Phone: 508-755-4861 Fax: 508-752-1392 | |
Mr. Donald James Desio, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 123 Summer St, Suite 150 S, Worcester, MA 01608 Phone: 508-368-3110 Fax: 508-368-3113 | |
Anne E. Garrison, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-6255 | |
Debra M Papa, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 33 Kendall St, Department Of Obstetrics & Gynecology, Worcester, MA 01605 Phone: 508-334-6255 Fax: 508-334-6063 |